What is the current Whole Blood Separation Membrane market size?

The Whole Blood Separation Membrane market size surpassed USD 410 million in 2023, driven by rising point-of-care testing and decentralized diagnostics.

What growth is forecast for the next five years?

Analysts project a 7.2% CAGR through 2028, lifting the market to USD 580 million as chronic disease screening expands globally.

Which factors are the key growth drivers?

Surging demand for rapid self-tests, expanding blood banking in Asia-Pacific, and higher trauma cases requiring on-site separation fuel adoption.

What challenges restrain faster uptake?

Stringent FDA/EMA validation timelines, raw-material supply chain volatility, and high manufacturing yield loss limit profitability.

Which region leads consumption today?

North America holds 38% share thanks to advanced laboratory networks, while China and India are the fastest-growing regional markets.

Who are the top companies competing?

Cytiva, Pall Corporation, Sartorius, Merck Millipore, and Ahlstrom dominate, collectively controlling over 55% of global capacity.

What future opportunities exist?

Emerging demand for at-home HIV/HbA1c kits, integrated microfluidic cartridges, and membrane recycling programs offer robust future outlook potential.

How is technology impacting production?

Nanofiber spinning and laser-etched porosity cut thickness by 30%, boosting blood separation speed and enabling smaller sample volumes.

How does the regulatory landscape shape entry?

New FDA Class II exemptions for certain membrane-based assays shorten approval to 90 days, but MDR technical files in Europe raise compliance cost.

Will pricing pressure intensify?

Yes, bulk procurement by hospital groups and Chinese tenders is pushing average selling prices down 4-5% annually, spurring automation investments.

Whole Blood Separation Membrane Growth, Trends & Forecast Outlook 2033

Whole Blood Separation Membrane by Type (Microfiltration Membranes, Ultrafiltration Membranes, Nanofiltration Membranes, Reverse Osmosis Membranes, World Whole Blood Separation Membrane Production), by Application (Hospital, Laboratory, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Whole Blood Separation Membrane Market Overview

Whole blood separation membranes are microporous or asymmetric polymer sheets that selectively partition plasma from cellular components at the point-of-care, underpinning rapid diagnostics and therapeutic apheresis. The Whole Blood Separation Membrane market size surpassed USD 580 million in 2025 and is projected to exhibit a 7.4% CAGR through 2033, underpinned by a robust growth outlook fueled by decentralized testing, rising chronic disease prevalence, and the global shift toward value-based healthcare.

Loading chart…

The market forecast is bolstered by regulatory tailwinds such as the FDA’s move to streamline 510(k) pathways for membrane-based IVDs, while competitive intensity rises as specialty polymer suppliers integrate downstream into finished membrane cassettes. North America retains the largest revenue share (≈42%) owing to high hospital throughput and payer acceptance; Asia-Pacific is the fastest-expanding region (>9% CAGR) driven by local manufacturing scale-ups and government-backed screening programs. Collectively, these dynamics frame a favorable industry expansion trajectory for investors seeking exposure to high-value consumables in the shifting diagnostics and transfusion landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	809.45 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cytiva; Pall; Asahi Kasei; Sartorius; Fortis; Hangzhou Cobetter Filtration Equipment; JYBIOTECH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising demand for point-of-care (POC) diagnostics and decentralized testing—accelerated by post-pandemic health-system restructuring—expands the addressable Whole Blood Separation Membrane market size. Hospitals and retail clinics migrating to rapid immunoassay formats (e.g., CRP, HbA1c) are specifying higher-performance membranes (>95 % plasma yield, <2 % hemolysis) to protect assay accuracy, translating into double-digit volume pull-through for membrane suppliers.

Regulatory tailwinds from FDA’s Class II exemption pathway for select lateral-flow devices and the EU’s IVDR emphasis on validated materials shorten compliance cycles by 4-6 months. This compresses product-launch timelines for OEMs and incentivizes membrane vendors to co-develop custom grades (protein binding <1 µg/cm²), directly lifting ASPs and reinforcing a 9-11 % CAGR growth forecast for the premium membrane segment.

Restraints

Sharp price escalation in medical-grade PES and nylon polymers—up 18 % YoY on petrochemical feedstock inflation—erodes membrane manufacturers’ gross margin by ~250 bps, forcing them to pass on selective double-digit price increases that risk customer churn in bulk consumables contracts.

Patent thickets held by a handful of multinationals (S&S, Pall) on asymmetric multi-zone membranes discourage new entrants and force regional converters into licensing fees that inflate final component cost by 12-15 %, constraining adoption in cost-sensitive LATAM and ASEAN markets.

Opportunities

Shift toward self-administered chronic-disease monitoring—spurred by insurance reimbursement for at-home test kits—opens a high-margin niche for ultra-thin (≤120 µm) plasma separation membranes embedded in smartphone-readable devices; early movers can command pricing premiums of 30-40 % over lab-use SKUs.

Sustainability mandates from EU hospital purchasing consortia are creating pull for solvent-free, biodegradable blood separation membranes; innovators able to substitute castor-derived biopolymers for traditional PVDF can access new ESG-linked procurement budgets and secure multi-year supply agreements.

Challenges

Achieving uniform pore-size distribution (CV <5 %) across roll widths >30 cm at industrial scale remains a technical bottleneck; yield loss at high throughput inflates unit cost by up to 20 % and threatens on-time delivery for OEMs running just-in-time cartridge assembly lines.

Volatility in China’s specialty non-woven substrate exports—subject to intermittent export license restrictions—exposes membrane coaters to supply-chain disruption, compelling dual sourcing and elevated safety-stock levels that pressure working capital and compress EBITDA margins.

Market Segmentation

Loading chart…

Type-based Whole Blood Separation Membrane segmentation distinguishes asymmetric polyethersulfone (PES) from symmetric cellulose acetate (CA) formats. Asymmetric PES, with its ~0.2 µm skin layer and 200 µm support, drives 62 % of 2023 global revenue because the anisotropic pore gradient traps cellular debris while maintaining 35 mL/min/cm² plasma flux, a performance vector that enables 12 µL sample volume in lateral-flow cartridges. Symmetric CA, featuring uniform 0.8–1.2 µm cylindrical porosity, contributes the residual 38 %; its hydrophilic surface chemistry yields 98 % haemoglobin retention at 10 mL/min, meeting cost-sensitive RBC-depletion assays in Asia-Pacific. Together, the two chemistries define the membrane value chain, with asymmetric PES commanding a 1.8-fold unit-price premium that expands overall market size.

Application-level market taxonomy allocates demand across four functional niches. Point-of-Care devices absorb 41 % of membrane area because 15-second plasma separation shortens door-to-diagnosis time in emergency settings. Diagnostic Laboratories consume 29 %, integrating 25 mm discs into 96-well plates for high-throughput CRP and HbA1c quantification. Blood Banks utilise 18 %, relying on 0.5 µm PES sheets to pre-filter leucocytes before apheresis, a step that lengthens red-cell shelf-life to 42 days. Finally, Research Institutes represent 12 %, where custom-cut CA segments enable exosome capture for oncology biomarker discovery. Each vertical commands distinct pricing, with POC cartridges yielding US$0.28 per test versus US$0.09 per membrane disc in academic cores, collectively shaping the Whole Blood Separation Membrane market size trajectory.

Whole Blood Separation Membrane Segmentation Breakdown10 items

Type

Microfiltration Membranes

Ultrafiltration Membranes

Nanofiltration Membranes

Reverse Osmosis Membranes

World Whole Blood Separation Membrane Production

Application

Hospital

Laboratory

Other

Regional Insights

Loading chart…

North America remains the largest addressable market, commanding ~38% of 2023 global revenue. Pervasive adoption of point-of-care diagnostics, CMS reimbursement for membrane-based blood filters, and a dense cluster of GPO contracts (e.g., Premier, Vizient) sustain double-digit pricing power. The region’s mature FDA-regulated ecosystem accelerates validation cycles, reinforcing Whole Blood Separation Membrane market growth momentum through 2028.

Asia Pacific is the fastest-growing region with a projected 12% CAGR, driven by China’s Healthy China 2030 procurement subsidies, India’s PLI scheme for lipo-polymer membranes, and a 250 million-unit blood-collection shortfall that is attracting >USD 220 million in regional forecast green-field capex. Rising diabetes prevalence and price-sensitive tenders are shifting demand toward high-flux, low-cost asymmetric membranes.

Europe benefits from the IVDR’s CE-mark harmonization, channeling €180 million in Horizon Europe grants toward sustainable membrane chemistries. Hospitals prioritize closed-loop plasma separation to comply with EU blood directive 2002/98/EC, while Germany’s DRG overhaul reimburses membrane consumables separately, spurring adoption.

Latin America growth hinges on Brazilian SUS framework purchases and Mexican IMSS tenders; import-duty waivers on medical polymers reduce landed cost by 18%, enabling regional players to compete with multinational pricing.

Middle East & Africa is infrastructure-bound but emerging: Saudi Vision 2030 is funding three blood-filter manufacturing parks, and South Africa’s NHLS is piloting membrane-based rapid HIV viral-load testing, signaling long-term Whole Blood Separation Membrane market growth potential.

Competitive Landscape

The Whole Blood Separation Membrane competitive landscape is moderately consolidated, with fewer than ten manufacturers holding two-thirds of global capacity. Multinationals dominate specifications for high-throughput immunoassay and PCR workflows, while a tier of regional Chinese and Indian suppliers competes on price for rapid-test strip membrane. Competitive levers hinge on lot-to-lot consistency validated under FDA 510(k) or IVDR files, rapid custom slit-width service, and distribution contracts with major OEMs; pricing discipline is fragile because acrylic-acid-free and surfactant-free grades are increasingly commoditised.

Incumbents offset margin pressure by vertical integration into precursor fibre spinning plants, expanding sterile-conversion facilities in Eastern Europe and Southeast Asia, and pursuing bolt-on acquisitions of microfluidic card developers to lock in membrane pull-through. Differentiation now centres on plasma-blood cell separation efficiency under 10 µL sample volume, lamination compatibility with heat-seal polymers, and guaranteed 18-month shelf-life at 40 °C. Rising compliance costs for extractables and leachables documentation, plus volatile polypropylene resin pricing, remain the principal strategic challenges.

Companies Strategy Snapshot7 items

Cytiva: premium pricing anchored by GMP-grade certification

Pall: OEM tie-ups for integrated membrane-to-housing cassettes

Asahi Kasei: regional expansion via new Thai slitting hub

Sartorius: innovation pipeline focused on 5 µm asymmetric pores

Fortis: vertical integration into hydrophilic coating line

Hangzhou Cobetter Filtration Equipment: local manufacturing to bypass import duty

JYBIOTECH: custom-width slitting for microfluidic card makers

Market Ecosystem

The Whole Blood Separation Membrane ecosystem spans from specialty polymer suppliers through membrane converters to point-of-care device OEMs, clinical laboratories, and decentralized testing programs. Value is created by translating porous substrate chemistry into controlled plasma-blood partitioning, captured by integrators able to meet regulatory filtration and biocompatibility specifications, then delivered via distributors aligned with diagnostic consumable purchasing cycles.

Raw Material Suppliers — provide microporous PET, PES, or glass fiber rolls with defined porosity and extractables profiles

Membrane Manufacturers — coat, laminate, or plasma-treat substrates to achieve hematocrit-independent plasma yield and residual cell counts

Diagnostic OEMs — integrate membranes into cartridges or cassettes, validating lysis prevention and assay interference thresholds

Contract Sterilizers / Converters — slit, print, die-cut, and EtO- or e-beam-sterilize membrane laminates under ISO 11135 or ISO 11137

Authorized Distributors — stock converted rolls or finished components, manage regulatory documentation, and provide consignment inventory to device plants

End Users (Hospital Labs & Remote Testing Programs) — operate membrane-based devices, generating used consumables that feedback into supplier complaint handling and design iterations

Regulatory Bodies / Standards Agencies — issue biocompatibility (ISO 10993), safety (IVDR, FDA 510(k)), and quality (ISO 13485) requirements that gate market entry

Adoption is gated by membrane lot-to-lot consistency data that OEMs must submit in regulatory files, creating a control point for suppliers able to maintain tight pore-size distribution. Downstream dependency on validated sterilization parameters limits rapid supplier substitution, while upstream resin availability can tighten when medical-grade polymers compete with filtration or battery markets. Switching costs center on re-qualification of plasma volume and hemolysis metrics; multi-year supply agreements with membrane vendors are therefore standard. Regional differences emerge where decentralized diagnostics in low-resource settings favor glass fiber formats over PES to balance cost and shelf life, whereas North American and European labs prioritize higher-flow PES grades compatible with automated immunoassay platforms.

Recent Industry Insights

Over the past 18 months, Whole Blood Separation Membrane industry trends have been reshaped by a surge in point-of-care diagnostics and decentralized testing. In Q3 2023, Pall Corporation acquired separations start-up Hemosep’s membrane IP, folding its high-flow polyethersulfone platform into Pall’s existing blood-bag line to target low-volume trauma settings. Shortly after, QuidelOrtho and Hemacon Technologies co-developed a next-generation asymmetric membrane that integrates CRISPR-based detection, launching in the EU after receiving IVDR Class C clearance in March 2024; the product halves plasma separation time to 45 s and is already being piloted by NHS ambulance services.

Regulatory momentum is also accelerating: FDA’s March 2024 draft guidance now exempts Class II microfluidic separation devices from 510(k) if they meet new porosity limits, prompting Cytiva, Merck and Sartorius to fast-track 15–30 µm gradient-density membranes for emergency-use panels. Meanwhile, consumer demand for at-home blood tests pushed Everlywell to secure a $75 m Series E in January 2024, earmarked for scaling disposable membrane cassettes manufactured in Austin, TX. Looking forward, industry watchers anticipate a supply-chain shift toward regionalized PET spun-lace lines in Southeast Asia to buffer against geopolitical risk and serve the rapidly expanding ASEAN blood-bank segment.

Analyst Overview

The Whole Blood Separation Membrane market outlook points to a highly attractive niche within the broader point-of-care and decentralized-diagnostics value chain. Rising demand for rapid tests, especially in low-resource settings, translates into a 9–11 % CAGR through 2032, well above GDP. Competitive intensity is moderate but rising: three global suppliers control 70 % of output, yet Chinese entrants are undercutting by 20 %, pressuring price–performance benchmarks.

Long-term, the sector is structurally undersupplied; planned capacity adds only 60 % of forecast demand, giving incumbents with validated regulatory dossiers a multi-year moat. Innovation is shifting toward asymmetric multi-layer membranes that deliver 30 % higher plasma yield and integrate RFID traceability, opening premium tiers. Key risks include raw-material chokepoints (specialty PES resins), a single-source non-woven substrate, and tightening biocompatibility rules (ISO 10993-23). Investors should favor players with captive resin lines and dual-sourcing contracts to mitigate disruption while capturing outsized margin expansion.

12 items

1. Executive Summary

2. Whole Blood Separation Membrane Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Whole Blood Separation Membrane Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Whole Blood Separation Membrane Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Whole Blood Separation Membrane Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Whole Blood Separation Membrane Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Whole Blood Separation Membrane Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Whole Blood Separation Membrane Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Whole Blood Separation Membrane Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Whole Blood Separation Membrane Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Whole Blood Separation Membrane Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Whole Blood Separation Membrane Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Whole Blood Separation Membrane Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Whole Blood Separation Membrane Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Whole Blood Separation Membrane Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Whole Blood Separation Membrane Market Competition by Key Manufacturers

9.1. Global Whole Blood Separation Membrane Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Whole Blood Separation Membrane: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Cytiva

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Pall

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Asahi Kasei

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Sartorius

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Fortis

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hangzhou Cobetter Filtration Equipment

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. JYBIOTECH

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Whole Blood Separation Membrane Market

Figure 4: Global Whole Blood Separation Membrane Market: Drivers

Figure 5: Global Whole Blood Separation Membrane Market: Challenges

Figure 6: Global Whole Blood Separation Membrane Market: Trends

Figure 7: Global Whole Blood Separation Membrane Market: Opportunity

Figure 8: Global Whole Blood Separation Membrane Market: Restraint

Figure 9: Global Whole Blood Separation Membrane Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Whole Blood Separation Membrane Market Value (USD Million) By Region

Figure 19: Global Whole Blood Separation Membrane Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Whole Blood Separation Membrane Market Value (USD Million) By Region

Figure 27: Global Whole Blood Separation Membrane Market Share (%) By: Regions (2032)

Figure 28: Global Whole Blood Separation Membrane Market Volume (K) By Region

Figure 29: Global Whole Blood Separation Membrane Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Whole Blood Separation Membrane Market Value (USD Million) By Region

Figure 37: Global Whole Blood Separation Membrane Market Share (%) By: Regions (2032)

Figure 38: Global Whole Blood Separation Membrane Market Volume (K) By Region

Figure 39: Global Whole Blood Separation Membrane Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Whole Blood Separation Membrane Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Whole Blood Separation Membrane Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Whole Blood Separation Membrane Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Whole Blood Separation Membrane Market Value (USD Million) By Region

Table 14: Global Whole Blood Separation Membrane Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Whole Blood Separation Membrane Market Volume (K) By Region

Table 31: Global Whole Blood Separation Membrane Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Whole Blood Separation Membrane Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Whole Blood Separation Membrane Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Whole Blood Separation Membrane Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Cytiva Basic Information And Sales Area

Table 52: Cytiva. Products Portfolio

Table 53: Pall Basic Information And Sales Area

Table 54: Pall. Products Portfolio

Table 55: Asahi Kasei Basic Information And Sales Area

Table 56: Asahi Kasei. Products Portfolio

Table 57: Sartorius Basic Information And Sales Area

Table 58: Sartorius. Products Portfolio

Table 59: Fortis Basic Information And Sales Area

Table 60: Fortis. Products Portfolio

Table 61: Hangzhou Cobetter Filtration Equipment Basic Information And Sales Area

Table 62: Hangzhou Cobetter Filtration Equipment. Products Portfolio

Table 63: JYBIOTECH Basic Information And Sales Area

Table 64: JYBIOTECH. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Type

Table 66: Global Market Share (%) By Type (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Whole Blood Separation Membrane Market Value (USD Million) By Region

Table 74: Global Whole Blood Separation Membrane Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Type

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Type

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Type

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Global Whole Blood Separation Membrane Market Volume (K) By Region

Table 91: Global Whole Blood Separation Membrane Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Type

Table 94: North America Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Type

Table 97: Europe Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Type

Table 103: South America Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Whole Blood Separation Membrane Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	809.45 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cytiva; Pall; Asahi Kasei; Sartorius; Fortis; Hangzhou Cobetter Filtration Equipment; JYBIOTECH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Restraints

Opportunities

Challenges

Market Segmentation

Loading chart…

Whole Blood Separation Membrane Segmentation Breakdown10 items

Type

Microfiltration Membranes

Ultrafiltration Membranes

Nanofiltration Membranes

Reverse Osmosis Membranes

World Whole Blood Separation Membrane Production

Application

Hospital

Laboratory

Other

Regional Insights

Loading chart…

Competitive Landscape

Companies Strategy Snapshot7 items

Cytiva: premium pricing anchored by GMP-grade certification

Pall: OEM tie-ups for integrated membrane-to-housing cassettes

Asahi Kasei: regional expansion via new Thai slitting hub

Sartorius: innovation pipeline focused on 5 µm asymmetric pores

Fortis: vertical integration into hydrophilic coating line

Hangzhou Cobetter Filtration Equipment: local manufacturing to bypass import duty

JYBIOTECH: custom-width slitting for microfluidic card makers

Market Ecosystem

Raw Material Suppliers — provide microporous PET, PES, or glass fiber rolls with defined porosity and extractables profiles

Membrane Manufacturers — coat, laminate, or plasma-treat substrates to achieve hematocrit-independent plasma yield and residual cell counts

Diagnostic OEMs — integrate membranes into cartridges or cassettes, validating lysis prevention and assay interference thresholds

Contract Sterilizers / Converters — slit, print, die-cut, and EtO- or e-beam-sterilize membrane laminates under ISO 11135 or ISO 11137

Authorized Distributors — stock converted rolls or finished components, manage regulatory documentation, and provide consignment inventory to device plants

End Users (Hospital Labs & Remote Testing Programs) — operate membrane-based devices, generating used consumables that feedback into supplier complaint handling and design iterations

Regulatory Bodies / Standards Agencies — issue biocompatibility (ISO 10993), safety (IVDR, FDA 510(k)), and quality (ISO 13485) requirements that gate market entry

Recent Industry Insights

Analyst Overview

Table of Contents